Accuray (ARAY) to Release Quarterly Earnings on Wednesday

Accuray (NASDAQ:ARAY) is scheduled to post its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Accuray to post earnings of ($0.04) per share for the quarter. Accuray has set its FY 2025 guidance at EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

Accuray (NASDAQ:ARAY) last released its earnings results on Wednesday, August 14th. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.03. Accuray had a negative return on equity of 33.65% and a negative net margin of 3.48%. The firm had revenue of $134.29 million during the quarter, compared to analyst estimates of $122.80 million. During the same period last year, the business posted ($0.03) earnings per share. On average, analysts expect Accuray to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Accuray Price Performance

ARAY opened at $1.82 on Tuesday. The company has a debt-to-equity ratio of 3.65, a current ratio of 1.66 and a quick ratio of 0.95. The business has a fifty day moving average price of $1.90 and a 200 day moving average price of $1.84. Accuray has a 12 month low of $1.40 and a 12 month high of $3.05.

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.